{"log_id": 7712654138205625215, "direction": 0, "words_result_num": 132, "words_result": [{"probability": {"variance": 0.000914, "average": 0.988812, "min": 0.854202}, "location": {"width": 432, "top": 62, "height": 21, "left": 48}, "words": "替丁使肝脏血流量降低,钙拮抗剂在肝微粒体的酶代谢被"}, {"probability": {"variance": 0.004863, "average": 0.982282, "min": 0.634239}, "location": {"width": 432, "top": 62, "height": 19, "left": 535}, "words": "大鼠长期毒性试验结果提示西尼地平对大鼠的无毒剂量为雄性大"}, {"probability": {"variance": 5.6e-05, "average": 0.996102, "min": 0.968143}, "location": {"width": 385, "top": 83, "height": 19, "left": 47}, "words": "抑制,另外使胃酸降低,从而使钙拮抗剂的吸收增加"}, {"probability": {"variance": 0.000828, "average": 0.982082, "min": 0.907559}, "location": {"width": 413, "top": 80, "height": 20, "left": 535}, "words": "鼠30mg/kg/日,雌性大鼠5mg/kg/日,异常表现为雌性动物"}, {"probability": {"variance": 0.003022, "average": 0.972882, "min": 0.830603}, "location": {"width": 121, "top": 103, "height": 17, "left": 47}, "words": "6.与利福平合用"}, {"probability": {"variance": 0.000139, "average": 0.992304, "min": 0.952297}, "location": {"width": 417, "top": 99, "height": 19, "left": 535}, "words": "25mg/kg剂量组,排便量减少、腹胀,摄水量和卵巢重量增加"}, {"probability": {"variance": 0.003646, "average": 0.984031, "min": 0.697047}, "location": {"width": 436, "top": 119, "height": 21, "left": 47}, "words": "钙拮抗剂与利福平台用有作用减弱的报道,可能是利福平诱"}, {"probability": {"variance": 0.023003, "average": 0.91216, "min": 0.451076}, "location": {"width": 429, "top": 119, "height": 19, "left": 536}, "words": "尿比重降低,雄鼠1 Cmg/kc剂星组,尿Na及尿C一排出量增加"}, {"probability": {"variance": 0.001621, "average": 0.99012, "min": 0.789471}, "location": {"width": 427, "top": 139, "height": 18, "left": 48}, "words": "导肝药酶,从而促进钙拮抗剂的代谢,使其清除率上升所致"}, {"probability": {"variance": 0.000119, "average": 0.994918, "min": 0.962591}, "location": {"width": 153, "top": 139, "height": 16, "left": 533}, "words": "但上述症状停药后消失"}, {"probability": {"variance": 0.009026, "average": 0.949347, "min": 0.714652}, "location": {"width": 187, "top": 159, "height": 17, "left": 48}, "words": "7.与偶氮类抗真菌药合用"}, {"probability": {"variance": 0.001342, "average": 0.987991, "min": 0.822284}, "location": {"width": 434, "top": 155, "height": 19, "left": 534}, "words": " Beadle犬长期毒性试验结果提示西尼地平对犬的无毒剂量"}, {"probability": {"variance": 0.014538, "average": 0.952258, "min": 0.52074}, "location": {"width": 430, "top": 176, "height": 19, "left": 48}, "words": "本品与偶氮类抗真菌药(如:酮康唑和伊曲康唑】合用时血"}, {"probability": {"variance": 0.004571, "average": 0.969926, "min": 0.668713}, "location": {"width": 429, "top": 175, "height": 19, "left": 537}, "words": "为6.25mg/kg/日,异常表现为25mg/kg以上剂量组,动物出"}, {"probability": {"variance": 0.005865, "average": 0.970152, "min": 0.723389}, "location": {"width": 431, "top": 195, "height": 19, "left": 47}, "words": "药浓度会增加,可能是偶氮类抗真菌药抑制了CYP3A4而减"}, {"probability": {"variance": 0.007397, "average": 0.963846, "min": 0.596833}, "location": {"width": 418, "top": 194, "height": 19, "left": 535}, "words": "现牙床肥大,副肾球犬带肥厚,100mg/kg剂量组体重增加抑"}, {"probability": {"variance": 0.000389, "average": 0.989826, "min": 0.93829}, "location": {"width": 133, "top": 216, "height": 18, "left": 48}, "words": "少本品的代谢所致"}, {"probability": {"variance": 0.013649, "average": 0.963431, "min": 0.388512}, "location": {"width": 399, "top": 212, "height": 20, "left": 535}, "words": "制,GP升高,副肾重量增加,上述症状停药后可自行恢复"}, {"probability": {"variance": 0.021905, "average": 0.923482, "min": 0.54832}, "location": {"width": 121, "top": 234, "height": 17, "left": 48}, "words": "8.与葡萄汁合月"}, {"probability": {"variance": 3e-06, "average": 0.998533, "min": 0.995357}, "location": {"width": 63, "top": 232, "height": 18, "left": 535}, "words": "生殖毒性"}, {"probability": {"variance": 0.000593, "average": 0.989274, "min": 0.870303}, "location": {"width": 429, "top": 251, "height": 19, "left": 48}, "words": "葡萄汁中某些成分可抑制CYP3A4而减少本品的代谢,从而"}, {"probability": {"variance": 0.00149, "average": 0.977731, "min": 0.865777}, "location": {"width": 421, "top": 250, "height": 18, "left": 536}, "words": "大鼠妊娠前及妊娠早期给予西尼地平,实验结果表明50mg/kg"}, {"probability": {"variance": 0.00028, "average": 0.993987, "min": 0.938589}, "location": {"width": 192, "top": 271, "height": 18, "left": 48}, "words": "导致本品的血药浓度上升。"}, {"probability": {"variance": 0.002663, "average": 0.977253, "min": 0.781036}, "location": {"width": 427, "top": 268, "height": 19, "left": 536}, "words": "以上剂量组出现早期死亡胎儿数增加,但对胎儿外形、内脏及骨"}, {"probability": {"variance": 9.6e-05, "average": 0.991888, "min": 0.970812}, "location": {"width": 86, "top": 290, "height": 17, "left": 46}, "words": "【药物过量】"}, {"probability": {"variance": 0.003615, "average": 0.96999, "min": 0.835723}, "location": {"width": 94, "top": 288, "height": 16, "left": 535}, "words": "骼无异常影响"}, {"probability": {"variance": 7.9e-05, "average": 0.996807, "min": 0.950981}, "location": {"width": 439, "top": 307, "height": 18, "left": 48}, "words": "据文献报导,过大剂量服用本品对中枢有先兴奋后抑制的作用,病"}, {"probability": {"variance": 0.003112, "average": 0.975291, "min": 0.764345}, "location": {"width": 432, "top": 305, "height": 19, "left": 535}, "words": "大鼠胎儿器官形成期口服给予西尼地平,结果表明100mg/kg以"}, {"probability": {"variance": 0.000509, "average": 0.989448, "min": 0.88756}, "location": {"width": 439, "top": 326, "height": 19, "left": 48}, "words": "人会出现血压极度降低甚至休克、头痛、呕吐、恶心等症状,应"}, {"probability": {"variance": 0.012594, "average": 0.963546, "min": 0.398138}, "location": {"width": 414, "top": 324, "height": 19, "left": 538}, "words": "上剂量组的母出现妊娠期延长,50mg/kg以上剂量组出现"}, {"probability": {"variance": 0.028993, "average": 0.924532, "min": 0.372918}, "location": {"width": 438, "top": 344, "height": 20, "left": 49}, "words": "立即给予升压药。洗青并服用活性炭促进肠道中未被吸的药物"}, {"probability": {"variance": 0.003009, "average": 0.978577, "min": 0.76257}, "location": {"width": 419, "top": 343, "height": 18, "left": 536}, "words": "胎儿骨骼变异及骨骼发育迟缓,具有一定的致畸性。家兔胎儿"}, {"probability": {"variance": 0.000267, "average": 0.993307, "min": 0.915766}, "location": {"width": 438, "top": 363, "height": 19, "left": 50}, "words": "自体内排泄,也可输液给予10%的葡萄糖促进已吸收的药物由肾"}, {"probability": {"variance": 0.000273, "average": 0.993815, "min": 0.908698}, "location": {"width": 421, "top": 362, "height": 18, "left": 536}, "words": "形成期口服给予尼地平的实验结果表明400mg/kg对母兔及胎"}, {"probability": {"variance": 3.6e-05, "average": 0.990219, "min": 0.984217}, "location": {"width": 31, "top": 383, "height": 17, "left": 51}, "words": "排泄"}, {"probability": {"variance": 9e-06, "average": 0.997707, "min": 0.992452}, "location": {"width": 65, "top": 381, "height": 18, "left": 535}, "words": "儿无影响"}, {"probability": {"variance": 2e-05, "average": 0.995924, "min": 0.987692}, "location": {"width": 85, "top": 402, "height": 18, "left": 48}, "words": "【临床试验】"}, {"probability": {"variance": 0.006037, "average": 0.975451, "min": 0.564621}, "location": {"width": 431, "top": 399, "height": 19, "left": 535}, "words": "大鼠围产期及授乳期口服给予西尼地平,实验结果表明24mg/kg"}, {"probability": {"variance": 0.008898, "average": 0.974139, "min": 0.496421}, "location": {"width": 429, "top": 419, "height": 19, "left": 48}, "words": "本品临床试验是采用多中心,随机、双盲双模拟、以西尼地平片"}, {"probability": {"variance": 0.002567, "average": 0.983743, "min": 0.738345}, "location": {"width": 430, "top": 418, "height": 18, "left": 535}, "words": "剂量组出现分娩时间延长,子宫内未排出残有胎儿数及新生胎仔"}, {"probability": {"variance": 0.004002, "average": 0.980826, "min": 0.750532}, "location": {"width": 430, "top": 438, "height": 18, "left": 50}, "words": "作阳性对照药物平行对照试验设计,对西尼地平胶囊治疗轻中度"}, {"probability": {"variance": 0.003257, "average": 0.980725, "min": 0.745018}, "location": {"width": 305, "top": 436, "height": 18, "left": 538}, "words": "存活数减少,对新生胎仔的发育、分无影响"}, {"probability": {"variance": 0.008026, "average": 0.981973, "min": 0.516487}, "location": {"width": 430, "top": 456, "height": 18, "left": 49}, "words": "原发性高血压的疗效和安全性进行评价。研究对象主要是年龄在"}, {"probability": {"variance": 7e-06, "average": 0.997553, "min": 0.993603}, "location": {"width": 78, "top": 455, "height": 17, "left": 538}, "words": "致突变作用"}, {"probability": {"variance": 0.0007, "average": 0.987647, "min": 0.887484}, "location": {"width": 428, "top": 474, "height": 18, "left": 52}, "words": "18-65岁的门诊或住院病人,男女均可;明确诊断为轻中度原发性"}, {"probability": {"variance": 0.000957, "average": 0.988771, "min": 0.888283}, "location": {"width": 431, "top": 472, "height": 19, "left": 537}, "words": "细菌回复突变实验、哺乳动物培养细胞染色体突变实验及小鼠微"}, {"probability": {"variance": 0.013348, "average": 0.937785, "min": 0.58365}, "location": {"width": 433, "top": 493, "height": 18, "left": 49}, "words": "高血压患者,在经2周模拟剂洗脱期后,坐位舒长90-100mmHg"}, {"probability": {"variance": 1.7e-05, "average": 0.997781, "min": 0.98441}, "location": {"width": 247, "top": 491, "height": 18, "left": 537}, "words": "核实验表明,尼地平无致突变作用"}, {"probability": {"variance": 0.018729, "average": 0.951866, "min": 0.336529}, "location": {"width": 429, "top": 512, "height": 19, "left": 50}, "words": "且坐位收缩压<180 Mmhg在试验过程中,受试者经2周模拟剂"}, {"probability": {"variance": 8e-06, "average": 0.996219, "min": 0.992571}, "location": {"width": 64, "top": 510, "height": 17, "left": 536}, "words": "致癌作用"}, {"probability": {"variance": 0.003068, "average": 0.970956, "min": 0.755558}, "location": {"width": 434, "top": 530, "height": 18, "left": 49}, "words": "洗脱期后,按11的比例随机分为二组(西尼地平胶囊组和西尼地平"}, {"probability": {"variance": 0.001069, "average": 0.988744, "min": 0.864731}, "location": {"width": 244, "top": 528, "height": 18, "left": 540}, "words": "小鼠和大鼠实验表明本品无致癌作用"}, {"probability": {"variance": 0.010614, "average": 0.963956, "min": 0.42863}, "location": {"width": 431, "top": 548, "height": 21, "left": 51}, "words": "片组);分别给予西尼地平胶囊规格:5mg/粒)粒/次1次/日"}, {"probability": {"variance": 5e-06, "average": 0.998727, "min": 0.993967}, "location": {"width": 101, "top": 547, "height": 17, "left": 535}, "words": "药代动力学】"}, {"probability": {"variance": 0.000569, "average": 0.990816, "min": 0.88173}, "location": {"width": 413, "top": 567, "height": 18, "left": 67}, "words": "和给予西尼地平片空白模拟剂1片/次,1次/日;或西尼地平"}, {"probability": {"variance": 0.006305, "average": 0.974948, "min": 0.57847}, "location": {"width": 427, "top": 565, "height": 19, "left": 538}, "words": "健康成年男子单次口服西尼地平,剂量分别为5mg.10mg和"}, {"probability": {"variance": 0.012932, "average": 0.947117, "min": 0.530571}, "location": {"width": 433, "top": 585, "height": 20, "left": 49}, "words": "片规格:5g/片)1片/次,1次/日,和西尼地平空白模拟剂1"}, {"probability": {"variance": 0.022588, "average": 0.911135, "min": 0.488413}, "location": {"width": 429, "top": 584, "height": 18, "left": 537}, "words": "20mg,此时血药峰浓度CTx(单位:ng/ml)分别为4.7、5.4和"}, {"probability": {"variance": 0.019364, "average": 0.93722, "min": 0.436398}, "location": {"width": 434, "top": 604, "height": 19, "left": 48}, "words": "粒/次,1次/日;于8am-10mj用治疗2周后,如血压降低未"}, {"probability": {"variance": 0.021077, "average": 0.891169, "min": 0.537307}, "location": {"width": 427, "top": 602, "height": 21, "left": 540}, "words": "1.7,AUC0-2a(ng,h/m)分别为23.7、27.5和60.1,呈剂"}, {"probability": {"variance": 0.016594, "average": 0.924505, "min": 0.512644}, "location": {"width": 431, "top": 623, "height": 19, "left": 49}, "words": "达标准(DBP=9mmHg),则分别将西尼地平胶囊或西尼地平片"}, {"probability": {"variance": 0.000407, "average": 0.987894, "min": 0.941851}, "location": {"width": 126, "top": 621, "height": 18, "left": 537}, "words": "量依赖性增加趋势"}, {"probability": {"variance": 0.006956, "average": 0.981166, "min": 0.540708}, "location": {"width": 431, "top": 641, "height": 19, "left": 49}, "words": "及相应空白模拟剂剂量加倍,再经6周治疗后,观察疗效。主要的"}, {"probability": {"variance": 0.002513, "average": 0.984232, "min": 0.723904}, "location": {"width": 423, "top": 639, "height": 19, "left": 537}, "words": "健康成年男子口服西足地平10mg,每日1次,连服7日,药代"}, {"probability": {"variance": 0.006405, "average": 0.963397, "min": 0.652333}, "location": {"width": 426, "top": 660, "height": 19, "left": 50}, "words": "观察指示泵血常规(包括血小板计数),尿常规,血液生化,心电图"}, {"probability": {"variance": 0.006482, "average": 0.972251, "min": 0.589812}, "location": {"width": 403, "top": 658, "height": 19, "left": 537}, "words": "动力学指标为:给药第1日,第4日,第7日的Cmax(单位"}, {"probability": {"variance": 0.007049, "average": 0.977291, "min": 0.538134}, "location": {"width": 436, "top": 679, "height": 20, "left": 50}, "words": "胸片或胸透,另对60位受试者进行动态血压检测。有效性结果为:"}, {"probability": {"variance": 0.017776, "average": 0.933843, "min": 0.426096}, "location": {"width": 418, "top": 677, "height": 20, "left": 537}, "words": "ng分别为9.5±1.6,13.5±5,16.9±79.Tmax(单位:小"}, {"probability": {"variance": 0.005442, "average": 0.965492, "min": 0.681811}, "location": {"width": 409, "top": 697, "height": 18, "left": 51}, "words": "本次试验共随机入组227例,其中试验组114例,对照组113例"}, {"probability": {"variance": 0.023521, "average": 0.920957, "min": 0.361156}, "location": {"width": 425, "top": 695, "height": 19, "left": 538}, "words": "时)分别为2.8=1,37±0.8,3±13,衰期T12(a)(单位:小"}, {"probability": {"variance": 0.020353, "average": 0.920016, "min": 0.494713}, "location": {"width": 429, "top": 717, "height": 18, "left": 52}, "words": "试验期间共脱落13例(5.72%);末进入PPS人群11例4.85%。对"}, {"probability": {"variance": 0.017999, "average": 0.91258, "min": 0.471368}, "location": {"width": 425, "top": 715, "height": 18, "left": 539}, "words": "时分别为1二02-1.1±0.6,T12(B)(单位:小时)5.2±2-8.1±27"}, {"probability": {"variance": 0.012692, "average": 0.921386, "min": 0.540409}, "location": {"width": 434, "top": 735, "height": 18, "left": 50}, "words": "PPS人群进行疗效分析:试验组101例,显效2O例(19.80%),有效"}, {"probability": {"variance": 0.016625, "average": 0.934526, "min": 0.424961}, "location": {"width": 390, "top": 734, "height": 17, "left": 553}, "words": "Auc∞(ng.h/ml)分别为59.1±12.7,108.1±29"}, {"probability": {"variance": 0.013909, "average": 0.94378, "min": 0.538389}, "location": {"width": 427, "top": 753, "height": 18, "left": 53}, "words": "59例58.42%),总有效率为18.22%;对照组102倒,显效16例"}, {"probability": {"variance": 0.006273, "average": 0.977012, "min": 0.576602}, "location": {"width": 418, "top": 752, "height": 17, "left": 540}, "words": "95.5±34.5月药第4天后,血药浓度开始稳定,未发现药物"}, {"probability": {"variance": 0.010047, "average": 0.944832, "min": 0.531342}, "location": {"width": 429, "top": 772, "height": 18, "left": 51}, "words": "(15.69%),有效66例64.71%),总有效率为80.40%,两组差异亦"}, {"probability": {"variance": 0.001583, "average": 0.975363, "min": 0.906533}, "location": {"width": 62, "top": 771, "height": 16, "left": 538}, "words": "蓄积情况"}, {"probability": {"variance": 0.009956, "average": 0.966619, "min": 0.528511}, "location": {"width": 431, "top": 790, "height": 18, "left": 51}, "words": "无统计学意义P>0.05)。安全性试验结果为:试验过程共发生不良"}, {"probability": {"variance": 0.000169, "average": 0.993473, "min": 0.934783}, "location": {"width": 426, "top": 788, "height": 20, "left": 539}, "words": "高血压患者单次口服10mg本品后的血药浓度变化,在肾功能正"}, {"probability": {"variance": 0.00306, "average": 0.986932, "min": 0.68698}, "location": {"width": 429, "top": 808, "height": 18, "left": 51}, "words": "事件39例,不良事件发生率为17.18%,试验组共发生不良事件"}, {"probability": {"variance": 0.021976, "average": 0.923747, "min": 0.411299}, "location": {"width": 416, "top": 807, "height": 18, "left": 539}, "words": "常和肾功能异常患者(血C:1.5-3.1mg/d)之间没有显著差异"}, {"probability": {"variance": 0.011173, "average": 0.960266, "min": 0.482503}, "location": {"width": 417, "top": 826, "height": 18, "left": 54}, "words": "20例(17.54%),其中与药物相关的不良事件为9例(7.89%"}, {"probability": {"variance": 0.015375, "average": 0.951009, "min": 0.520823}, "location": {"width": 432, "top": 826, "height": 18, "left": 538}, "words": "肾功能低下的患者每日1次服用本品10mg,连续用药7日,其血"}, {"probability": {"variance": 0.004072, "average": 0.984803, "min": 0.631999}, "location": {"width": 432, "top": 845, "height": 18, "left": 51}, "words": "对照组共发生不良事件19例(16.81%),其中与药物相关的不良"}, {"probability": {"variance": 0.000185, "average": 0.994703, "min": 0.941343}, "location": {"width": 266, "top": 844, "height": 18, "left": 539}, "words": "药浓度的变化不会因多次服药而受影响"}, {"probability": {"variance": 0.011331, "average": 0.950177, "min": 0.612064}, "location": {"width": 432, "top": 864, "height": 18, "left": 51}, "words": "事件为10例8.85%)。不良事件与相关不良事件发生率两组的差"}, {"probability": {"variance": 0.01196, "average": 0.965167, "min": 0.368057}, "location": {"width": 432, "top": 861, "height": 23, "left": 540}, "words": "在健康成年人,本品主要在肝脏经CYP3A和CYP2C19代谢,"}, {"probability": {"variance": 0.000929, "average": 0.986547, "min": 0.869197}, "location": {"width": 425, "top": 882, "height": 18, "left": 51}, "words": "异均无统计学意义,试验过程中主要的不良反应主为口干,心悸"}, {"probability": {"variance": 0.018218, "average": 0.957592, "min": 0.451855}, "location": {"width": 430, "top": 880, "height": 19, "left": 539}, "words": "谢途径为甲氧基乙基的脱甲氧化,肉桂酯的加水分解以及二氢"}, {"probability": {"variance": 0.000199, "average": 0.994603, "min": 0.937175}, "location": {"width": 432, "top": 901, "height": 19, "left": 51}, "words": "头晕,头痛,耳鸣,下肢乏力;试验过程中出现例与药物相关的"}, {"probability": {"variance": 0.003883, "average": 0.978349, "min": 0.656397}, "location": {"width": 423, "top": 900, "height": 18, "left": 539}, "words": "啶的氧化。健康成年男子每日2次服用本品10mg,连续7天,尿"}, {"probability": {"variance": 0.002948, "average": 0.97223, "min": 0.766728}, "location": {"width": 432, "top": 920, "height": 18, "left": 51}, "words": "不良反应,1例为UA升高,另1例为WBC降低,复查时已恢复正常"}, {"probability": {"variance": 0.001254, "average": 0.990956, "min": 0.804741}, "location": {"width": 432, "top": 919, "height": 18, "left": 539}, "words": "中未检测出药物原形,代谢产物占总服药量的52%,体外试验发"}, {"probability": {"variance": 0.002554, "average": 0.988897, "min": 0.731541}, "location": {"width": 416, "top": 938, "height": 19, "left": 67}, "words": "本试验结论为西尼地平胶囊是治疗轻、中度原发性高血压安全"}, {"probability": {"variance": 0.003698, "average": 0.97461, "min": 0.802476}, "location": {"width": 218, "top": 938, "height": 18, "left": 538}, "words": "现人体血清蛋白结合率为99.3%"}, {"probability": {"variance": 0.033596, "average": 0.916858, "min": 0.50701}, "location": {"width": 90, "top": 958, "height": 17, "left": 53}, "words": "血有效的药物"}, {"probability": {"variance": 0.001816, "average": 0.980779, "min": 0.854939}, "location": {"width": 195, "top": 955, "height": 19, "left": 537}, "words": "【贮藏】光、密闭保存"}, {"probability": {"variance": 0.00024, "average": 0.987506, "min": 0.958097}, "location": {"width": 85, "top": 975, "height": 18, "left": 49}, "words": "【药理毒理"}, {"probability": {"variance": 0.015433, "average": 0.940581, "min": 0.492965}, "location": {"width": 408, "top": 975, "height": 19, "left": 547}, "words": "包装】聚氯乙烯固体药用硬片,药用铝笋。7粒/板/盒。"}, {"probability": {"variance": 0.007457, "average": 0.949522, "min": 0.799952}, "location": {"width": 63, "top": 995, "height": 17, "left": 51}, "words": "药理作月"}, {"probability": {"variance": 1.2e-05, "average": 0.996507, "min": 0.991991}, "location": {"width": 125, "top": 992, "height": 19, "left": 546}, "words": "有效期】24个月"}, {"probability": {"variance": 0.003167, "average": 0.976945, "min": 0.715468}, "location": {"width": 434, "top": 1012, "height": 19, "left": 51}, "words": "本品为亲脂性的二氢吡啶类钙拮抗剂,能与血管平滑肌膜上L型"}, {"probability": {"variance": 0.005616, "average": 0.977791, "min": 0.596241}, "location": {"width": 388, "top": 1011, "height": 19, "left": 547}, "words": "执行标准】国家食品药品监督管理局标准YBH01712008"}, {"probability": {"variance": 0.006439, "average": 0.961015, "min": 0.631288}, "location": {"width": 433, "top": 1032, "height": 17, "left": 51}, "words": "钙通道的二气吡啶位点结合,抑制Ca通过L型钙通道的跨膜内"}, {"probability": {"variance": 0.00104, "average": 0.975616, "min": 0.874387}, "location": {"width": 226, "top": 1031, "height": 17, "left": 548}, "words": "批准文号】国药准字H20080066"}, {"probability": {"variance": 0.006933, "average": 0.959887, "min": 0.704431}, "location": {"width": 433, "top": 1050, "height": 18, "left": 51}, "words": "流,从而松弛,扩张血管平滑肌,起到降压作用。它还可通过抑"}, {"probability": {"variance": 4.9e-05, "average": 0.995978, "min": 0.982046}, "location": {"width": 84, "top": 1049, "height": 18, "left": 537}, "words": "【生产企业"}, {"probability": {"variance": 0.000814, "average": 0.989566, "min": 0.876116}, "location": {"width": 433, "top": 1068, "height": 18, "left": 52}, "words": "制Ca通过交感神经细胞膜上N型钙通道的跨膜内流而抑制交感"}, {"probability": {"variance": 0.000392, "average": 0.990626, "min": 0.934846}, "location": {"width": 262, "top": 1067, "height": 18, "left": 547}, "words": "企业名称:湖南九典制药股份有限公司"}, {"probability": {"variance": 0.00049, "average": 0.989802, "min": 0.899681}, "location": {"width": 309, "top": 1086, "height": 18, "left": 52}, "words": "神经末梢去甲肾上腺素的释放和交感神经活动"}, {"probability": {"variance": 0.008632, "average": 0.973275, "min": 0.638323}, "location": {"width": 217, "top": 1086, "height": 18, "left": 547}, "words": "生产地址:湖南浏阳生物医药园"}, {"probability": {"variance": 0.000151, "average": 0.9915, "min": 0.970239}, "location": {"width": 61, "top": 1105, "height": 17, "left": 51}, "words": "急性毒性"}, {"probability": {"variance": 0.006726, "average": 0.970859, "min": 0.711815}, "location": {"width": 134, "top": 1105, "height": 16, "left": 548}, "words": "邮政编码:410331"}, {"probability": {"variance": 0.01089, "average": 0.970142, "min": 0.490112}, "location": {"width": 431, "top": 1123, "height": 18, "left": 52}, "words": "小鼠急性毒性试验结果表明单次灌服西足地平片的最大对药量为"}, {"probability": {"variance": 0.001125, "average": 0.982301, "min": 0.88023}, "location": {"width": 316, "top": 1123, "height": 17, "left": 548}, "words": "电话号码:0795-73786270795-7373605"}, {"probability": {"variance": 0.028732, "average": 0.734755, "min": 0.587009}, "location": {"width": 51, "top": 1144, "height": 16, "left": 55}, "words": " 10g/kg"}, {"probability": {"variance": 0.0011, "average": 0.983595, "min": 0.885465}, "location": {"width": 214, "top": 1143, "height": 15, "left": 623}, "words": "0731-8822022088220228"}, {"probability": {"variance": 1e-06, "average": 0.999199, "min": 0.997516}, "location": {"width": 78, "top": 1161, "height": 17, "left": 55}, "words": "亚急性毒性"}, {"probability": {"variance": 0.00137, "average": 0.988853, "min": 0.79499}, "location": {"width": 329, "top": 1159, "height": 19, "left": 547}, "words": "传真号码:0795-73786270731-88220238"}, {"probability": {"variance": 0.000428, "average": 0.992194, "min": 0.911945}, "location": {"width": 431, "top": 1179, "height": 19, "left": 55}, "words": "大鼠亚急性毒性试验结果提示西尼地平对大鼠的无毒剂量为雄性"}, {"probability": {"variance": 0.008993, "average": 0.932917, "min": 0.613823}, "location": {"width": 272, "top": 1179, "height": 19, "left": 547}, "words": "网址:http:/www. jiudian.com"}, {"probability": {"variance": 0.006657, "average": 0.963167, "min": 0.617085}, "location": {"width": 431, "top": 1199, "height": 18, "left": 51}, "words": "大鼠50mg/kg/日,雌性大鼠6.25mg/kg/日,异常表现为雄性动"}, {"probability": {"variance": 0.009382, "average": 0.951643, "min": 0.589866}, "location": {"width": 433, "top": 1216, "height": 20, "left": 52}, "words": "物12.5mg/kg以上剂量组血清C一减少,25mg/kg以上剂量组出"}, {"probability": {"variance": 0.002343, "average": 0.974878, "min": 0.761778}, "location": {"width": 433, "top": 1235, "height": 19, "left": 51}, "words": "现腹胀、50mg/kg以上剂量组卵巢重量增加,100mg/kg以上剂"}, {"probability": {"variance": 0.018728, "average": 0.951585, "min": 0.469682}, "location": {"width": 414, "top": 1255, "height": 16, "left": 52}, "words": "量组雌雄均可见肝脏重量增加,但这些异常改变在停药后消失"}, {"probability": {"variance": 4.3e-05, "average": 0.996454, "min": 0.970922}, "location": {"width": 433, "top": 1272, "height": 18, "left": 54}, "words": " Beagle犬亚急性毒性试验结果提示西尼地平对犬的无毒剂量为"}, {"probability": {"variance": 0.004777, "average": 0.973301, "min": 0.663293}, "location": {"width": 432, "top": 1291, "height": 17, "left": 51}, "words": "25mg/kg/日,异常表现为雌性动物50mg片以上剂量组可见一"}, {"probability": {"variance": 0.007851, "average": 0.971889, "min": 0.535693}, "location": {"width": 431, "top": 1309, "height": 19, "left": 52}, "words": "过性眼及口腔粘膜苍白、呕吐、雄性动物50mgkg以上剂量组出"}, {"probability": {"variance": 0.008529, "average": 0.964984, "min": 0.587526}, "location": {"width": 304, "top": 1328, "height": 17, "left": 52}, "words": "现Q一间期延长,上述症状停药后可自行恢复"}, {"probability": {"variance": 0, "average": 0.999876, "min": 0.999731}, "location": {"width": 62, "top": 1345, "height": 19, "left": 52}, "words": "长期毒性"}, {"probability": {"variance": 0.02795, "average": 0.907873, "min": 0.483868}, "location": {"width": 63, "top": 1353, "height": 13, "left": 911}, "words": "20170605"}], "language": 3}